Effects of obesity surgery on non–insulin-dependent diabetes mellitus

SE Greenway, FL Greenway, S Klein - Archives of Surgery, 2002 - jamanetwork.com
Context Most individuals who have non–insulin-dependent diabetes mellitus are obese. The
obese population has proved a frustrating entity regarding weight loss and diabetes control …

Treatment of adolescent overweight and obesity

MD Tsiros, N Sinn, AM Coates, PRC Howe… - European journal of …, 2008 - Springer
Adolescence is a vulnerable period for the development of obesity, and adolescent weight
tracks strongly into adulthood. Previous reviews of treatment strategies have failed to …

Weight loss maintenance

SN Grief, RLF Miranda - American family physician, 2010 - aafp.org
Successful long-term weight loss maintenance can be achieved by various means. A
combination of dietary and physical activity interventions, along with one or more behavioral …

Therapeutic options for modifying cardiometabolic risk factors

LJ Aronne - The American journal of medicine, 2007 - Elsevier
Excessive adipose tissue is associated with increased expression or suppression of
cytokines and hormones, leading to inflammation and chronic disease. In particular …

Is it time to abandon excess weight loss in reporting surgical weight loss?

S Karmali, DW Birch, AM Sharma - Surgery for Obesity and Related …, 2009 - soard.org
Excess weight loss (EWL), calculated as the actual weight loss divided by the “excess”
weight 100 [1], is widely used in the bariatric surgical data to report on weight outcomes [2] …

[PDF][PDF] Withdrawal of sibutramine for weight loss: where does this leave clinicians?

S Czernichow, GD Batty - Obesity facts, 2010 - karger.com
As has been well documented, the disorders of overweight and obesity currently affect more
than 1.1 billion people worldwide [1]. In several developed countries more than two thirds of …

The endocannabinoid system as a target for obesity treatment

LJ Aronne, U Pagotto, GD Foster, SN Davis - Clinical Cornerstone, 2008 - Elsevier
Overweight and obesity are major factors contributing to the development of type 2 diabetes
mellitus (DM) and cardiovascular disease (CVD). In addition to the many physical and …

Thinking around abdominal obesity and cardiovascular risk

I Broom - The British Journal of Diabetes & Vascular …, 2006 - journals.sagepub.com
Obesity, particularly intra-abdominal (visceral) obesity, is a leading cause of cardiovascular
disease (CVD), insulin resistance, type 2 diabetes, dyslipidaemia, inflammation and …

Коррекция метаболических нарушений сибутрамином как способ восстановления эндокринной функции репродуктивной системы у женщин с ожирением

ГЕ Чернуха, ВП Сметник, ЛИ Мовсисян - Гинекология, 2004 - elibrary.ru
В настоящее время ожирение рассматривается как хроническое заболевание,
сопряженное с высоким риском развития не только сахарного диабета типа 2 (СД 2) …

Síndrome metabólico

DS Fuentes, MB Sánchez - Medicine-Programa de Formación Médica …, 2008 - Elsevier
No hay una definición universalmente aceptada del SM y su diagnóstico se realiza en
función del cumplimiento de unos criterios propuestos para este fin. En la actualidad hay al …